MedTrace Logo

The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9)

NCT04579159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 882

Last updated 2022-07-07

No results posted yet for this study

Summary

This feasibility study will develop and evaluate pathways to identify participants with wearable-detected absoulute Arrhythmia (AA) and to enable local study teams to contact them regarding participation in a controlled trial of oral anticoagulation in this population, which will be conducted after the feasibility study.

Conditions

  • Atrial Arrhythmia

Interventions

DEVICE

Preventicus heartbeat app in combination with wearables

CE certified devices

Sponsors & Collaborators

  • Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

    collaborator INDUSTRY

  • Preventicus GmbH

    collaborator INDUSTRY

  • Corsano/ MMT

    collaborator UNKNOWN

  • Getemed Medizin- und Informationstechnik

    collaborator UNKNOWN

  • Atrial Fibrillation Network

    lead OTHER

Principal Investigators

  • Larissa Fabritz, Professor · Institute of Cardiovascular Sciences, University of Birmingham

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-26
Primary Completion
2022-02-25
Completion
2022-02-25

Countries

  • Germany
  • Poland
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579159 on ClinicalTrials.gov